丙戊酸提高长时间损伤控制复苏猪模型的生存率并降低复苏需求
该研究为动物实验,15头约克夏猪(40-45 kg)经致死性失血性休克(估计总血容量50%)后随机分为三组:失血性休克组、失血性休克+损伤控制复苏组、失血性休克+损伤控制复苏+丙戊酸组(150 mg/kg,3小时输注),每组5头。损伤控制复苏按战术战伤救治指南在休克期1小时开始,目标收缩压80 mmHg,72小时后存活动物输注浓缩红细胞模拟后送。未治疗组生存率为0%,损伤控制复苏组生存率20%(无统计学显著性),加用丙戊酸组生存率80%(p<0.01)。丙戊酸组收缩压更高、液体复苏需求更低、血红蛋白更高、肌酐和钾更低(p<0.05)。
要点
- 在致死性失血性休克猪模型中,未治疗组生存率0%,损伤控制复苏组20%,损伤控制复苏+丙戊酸组80%(p<0.01)。
- 丙戊酸组较损伤控制复苏组收缩压更高、液体复苏需求更低、血红蛋白更高、肌酐和钾更低(p<0.05)。
- 丙戊酸给药方案为150 mg/kg,3小时输注,在休克期1小时开始损伤控制复苏时加用。
- 损伤控制复苏按战术战伤救治指南实施,目标收缩压80 mmHg,持续72小时。
- 该模型为动物实验,结论尚不能直接转化为临床推荐。
适用人群与场景
- 约克夏猪(40-45 kg),致死性失血性休克(估计总血容量50%),模拟长时间损伤控制复苏场景。
诊断标准与关键阈值
- 致死性失血性休克模型:估计总血容量50%的失血量。
处置流程与药物剂量
- 损伤控制复苏组:休克期1小时开始按战术战伤救治指南实施,目标收缩压80 mmHg,持续72小时。
- 丙戊酸组:在损伤控制复苏基础上加用丙戊酸150 mg/kg,3小时输注。
- 72小时时存活动物输注浓缩红细胞,模拟后送至更高级别救治机构。
研究设计与关键结果
- 动物实验,15头猪随机分三组(每组5头):失血性休克组、失血性休克+损伤控制复苏组、失血性休克+损伤控制复苏+丙戊酸组。
- 未治疗组生存率0%,损伤控制复苏组20%(无统计学显著性),加用丙戊酸组80%(p<0.01)。
- 丙戊酸组较损伤控制复苏组收缩压更高、液体复苏需求更低、血红蛋白更高、肌酐和钾更低(p<0.05)。
证据类型、等级与局限
- 证据类型:动物实验(猪致死性失血性休克模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在长时间损伤控制复苏中加用丙戊酸可提高生存率、降低复苏需求并改善血流动力学和实验室指标。
- 该结果为动物实验,尚不能直接转化为急诊/ICU临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although damage control resuscitation (DCR) is routinely performed for short durations, prolonged DCR may be required in military conflicts as a component of prolonged field care. Valproic acid (VPA) has been shown to have beneficial properties in lethal hemorrhage/trauma models. We sought to investigate whether the addition of a single dose of VPA to a 72-hour prolonged DCR protocol would improve clinical outcomes.
METHODS: Fifteen Yorkshire swine (40-45 kg) were subjected to lethal (50% estimated total blood volume) hemorrhagic shock (HS) and randomized to three groups: (1) HS, (2) HS-DCR, (3) HS-DCR-VPA (150 mg/kg over 3 hours) (n = 5/cohort). In groups assigned to receive DCR, Tactical Combat Casualty Care guidelines were applied (1 hour into the shock period), targeting a systolic blood pressure of 80 mm Hg. At 72 hours, surviving animals were given transfusion of packed red blood cells, simulating evacuation to higher echelons of care. Survival rates, physiologic parameters, resuscitative fluid requirements, and laboratory profiles were used to compare the clinical outcomes.
RESULTS: This model was 100% lethal in the untreated animals. DCR improved survival to 20%, although this was not statistically significant. The addition of VPA to DCR significantly improved survival to 80% (p < 0.01). The VPA-treated animals also had significantly (p < 0.05) higher systolic blood pressures, lower fluid resuscitation requirements, higher hemoglobin levels, and lower creatinine and potassium levels.
CONCLUSION: VPA administration improves survival, decreases resuscitation requirements, and improves hemodynamic and laboratory parameters when added to prolonged DCR in a lethal hemorrhage model.
参考来源
- Williams AM, Bhatti UF, Biesterveld BE, et al. Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation. J Trauma Acute Care Surg. 2019. PMID: 31206419. doi:10.1097/TA.0000000000002281
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。